Tyrosine kinase blocking collagen IV–derived peptide suppresses ocular neovascularization and vascular leakage

An integrin-binding peptide derived from collagen IV prevents ligand-induced activation of multiple tyrosine kinase receptors and strongly suppresses ocular neovascularization and vascular leakage.